Skip to content
Apex Nursing

Guide — Critical Care

CRRT Basics for Nurses

What continuous renal replacement therapy is, why it is used in the ICU instead of standard dialysis, how each modality works, and what nurses monitor throughout therapy.

12 min read · Critical Care

Educational use only. CRRT management is a complex clinical skill requiring institutional training and physician/advanced practice orders. This content is for learning purposes only. Follow your institution's CRRT protocols for all patient care decisions. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.

What Is CRRT and Why Use It?

Continuous renal replacement therapy (CRRT) is a slow, continuous form of renal replacement therapy performed 24 hours a day. Unlike conventional intermittent hemodialysis (IHD), which removes large amounts of fluid and solutes rapidly over 3–4 hours, CRRT removes them gradually and continuously.

Why CRRT in the ICU? Critically ill patients are often hemodynamically unstable. Rapid fluid and solute shifts during conventional HD cause hypotension in patients who cannot tolerate it. CRRT avoids these shifts by operating slowly — making it the preferred modality for hemodynamically unstable patients with acute kidney injury.

Indications for CRRT

Acute Kidney Injury (AKI) with Hemodynamic InstabilityThe primary indication. Patients who cannot tolerate the rapid fluid shifts of intermittent HD — including those on vasopressors or with cardiogenic shock.
Severe Fluid OverloadCRRT allows precise, controlled fluid removal (net ultrafiltration) that can be adjusted hourly. Critical in patients with acute pulmonary edema or severe anasarca.
Refractory Electrolyte ImbalancesLife-threatening hyperkalemia, severe hyponatremia, or severe hyperphosphatemia that cannot be managed medically.
Metabolic AcidosisSevere uremic acidosis unresponsive to bicarbonate therapy, often seen in anuric AKI.
Drug or Toxin RemovalFor dialyzable toxins (lithium, salicylates, methanol) in patients who are hemodynamically unstable for conventional HD.
Sepsis with Cytokine OverloadEmerging use — high-volume CRRT or special adsorption filters to remove inflammatory mediators in severe septic shock.

How CRRT Cleans the Blood: Convection vs. Diffusion

Convection (Solvent Drag)

Fluid is pushed across a semipermeable membrane under pressure, carrying solutes with it — like squeezing water through a screen. Larger molecules (middle molecules) are cleared effectively. Requires replacement fluid to maintain volume balance.

Diffusion (Dialysis)

Solutes move across a membrane from an area of high concentration (blood) to low concentration (dialysate flowing countercurrent). Highly effective for small molecules (urea, creatinine, potassium). Does not require replacement fluid.

CRRT Modalities

CVVH — Continuous Veno-Venous Hemofiltration

Mechanism: Convection only
Dialysate: No dialysate
Replacement Fluid: Replacement fluid required (pre-filter or post-filter)
Best Clears: Middle molecules; moderate small molecule clearance
Best For: Fluid removal and middle-molecule clearance; cytokine removal
Clinical Note: Pre-dilution (replacement before filter) reduces clotting but dilutes clearance. Post-dilution maximizes clearance but increases clotting risk.

CVVHD — Continuous Veno-Venous Hemodialysis

Mechanism: Diffusion only
Dialysate: Dialysate flows countercurrent through circuit
Replacement Fluid: No replacement fluid
Best Clears: Small molecules (urea, creatinine, K+) — highly efficient
Best For: Electrolyte and uremic solute clearance when middle-molecule removal is less critical
Clinical Note: Best for classic uremia and hyperkalemia management. Less effective for cytokine clearance due to pure diffusion.

CVVHDF — Continuous Veno-Venous Hemodiafiltration

Mechanism: Convection + Diffusion combined
Dialysate: Yes — dialysate used
Replacement Fluid: Yes — replacement fluid used
Best Clears: Both small and middle molecules; broadest clearance spectrum
Best For: Most common modality for general ICU AKI — combines the benefits of both CVVH and CVVHD
Clinical Note: Higher complexity (two fluids to manage) but maximizes total solute removal. Typical choice in most ICU CRRT programs.

Anticoagulation in CRRT

The extracorporeal circuit triggers the clotting cascade. Anticoagulation is required to maintain filter patency and extend circuit life (target: 24–72 hours per filter).

AgentMechanismMonitoringNotes
Systemic HeparinSystemic anticoagulation via antithrombin IIIaPTT 45–60 sec; anti-Xa levels at some centersSimple; increased bleeding risk; contraindicated in HIT
Regional CitrateChelates ionized calcium in circuit (Ca2+ required for coagulation)Ionized Ca2+ in circuit (0.25–0.35 mmol/L), systemic ionized Ca2+ (1.12–1.35 mmol/L)Preferred when bleeding risk is high; extends filter life; requires calcium replacement infusion
ArgatrobanDirect thrombin inhibitor; no platelet involvementaPTT or ACT per protocolUse when heparin contraindicated (HIT); hepatically metabolized — adjust in liver failure
No AnticoagulationN/AVisual circuit inspection; filter pressure monitoringUsed when systemic anticoagulation risk is unacceptably high; shorter circuit life expected

Fluid Management and Net Fluid Removal

CRRT allows precise hourly fluid balance management. The key concept is net ultrafiltration (net UF) — the difference between what is removed (effluent) and what is replaced (replacement fluid + dialysate).

The physician sets a net fluid removal goal (e.g., “remove 100 mL/hr net”). The nurse monitors the cumulative fluid balance and makes adjustments to maintain the prescribed net removal rate, accounting for all other fluid inputs and outputs.

Example: Effluent rate 2,000 mL/hr. Replacement fluid 1,800 mL/hr. Net UF = 200 mL/hr. Over 24 hours: 4,800 mL net fluid removal.

Hypotension is the most common complication of overly aggressive net fluid removal in hemodynamically unstable patients. Monitor BP continuously and notify the provider if MAP drops below target during therapy.

Nursing Monitoring Priorities

Circuit Pressure MonitoringAccess pressure, return pressure, transmembrane pressure (TMP), and filter pressure drop are continuously displayed. Rising TMP or filter pressure difference indicates clotting. Know your institution's thresholds for circuit intervention.
ElectrolytesCheck potassium, calcium (especially with citrate), sodium, magnesium, and phosphorus every 4–6 hours. CRRT can cause profound hypokalemia, hypophosphatemia, and citrate-related hypocalcemia.
TemperatureCRRT circuits are not heated externally and blood cooling can cause significant hypothermia over 24 hours. Monitor temperature closely and use warming blankets or heated replacement fluids as indicated.
Access PatencyCRRT requires a large-bore double-lumen catheter (typically femoral or internal jugular). Assess for kinking, positional flow interruptions, and signs of catheter-related infection.
Fluid BalanceDocument all inputs and outputs meticulously. Cumulative fluid balance must be reconciled against the prescribed net removal goal every hour. Small errors compound over 24 hours.
Filter LifeDocument filter start time. Note if clot formation is occurring early (before 12 hours) — this may indicate inadequate anticoagulation or subtherapeutic citrate levels.

NCLEX / CCRN Pearls

  • CRRT is preferred over intermittent HD in hemodynamically unstable ICU patients because it avoids rapid fluid and solute shifts.
  • CVVH uses convection only; CVVHD uses diffusion only; CVVHDF uses both — CVVHDF is most common in ICUs.
  • Regional citrate anticoagulation chelates calcium in the circuit — systemic calcium replacement is always required alongside it.
  • CRRT can cause profound hypokalemia, hypophosphatemia, and hypothermia — all require active monitoring and correction.
  • Hypotension during CRRT is usually from overly aggressive net fluid removal; reduce the net UF rate and notify the provider.
  • Rising transmembrane pressure (TMP) indicates filter clotting — assess anticoagulation adequacy and prepare for filter change.

Related Resources

Standards & sources

Fact-checked Jun 20, 2026

This page is written to align with Society of Critical Care Medicine (SCCM) · Surviving Sepsis Campaign · American Association of Critical-Care Nurses (AACN). It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →